scispace - formally typeset
Open AccessJournal ArticleDOI

The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery

Reads0
Chats0
TLDR
Although non‐targeted and non‐conjugatable, ICG appears to be laying the foundation for more widespread use of NIR fluorescence‐guided surgery, understanding its advantages and limitations is of significant importance.
Abstract
Optical imaging using near-infrared (NIR) fluorescence provides new prospects for general and oncologic surgery. ICG is currently utilised in NIR fluorescence cancer-related surgery for three indications: sentinel lymph node (SLN) mapping, intraoperative identification of solid tumours, and angiography during reconstructive surgery. Therefore, understanding its advantages and limitations is of significant importance. Although non-targeted and non-conjugatable, ICG appears to be laying the foundation for more widespread use of NIR fluorescence-guided surgery.

read more

Citations
More filters
Journal ArticleDOI

Near-infrared fluorophores for biomedical imaging

TL;DR: This Review covers recent progress on near-infrared fluorescence imaging for preclinical animal studies and clinical diagnostics and interventions.
Journal ArticleDOI

Image-guided cancer surgery using near-infrared fluorescence.

TL;DR: The concept of NIR fluorescence imaging for cancer surgery is introduced, the clinical trial literature to date is examined, and the key issues pertaining to imaging system and contrast agent optimization are outlined.
Journal ArticleDOI

A review of indocyanine green fluorescent imaging in surgery

TL;DR: An overview of the recent surgical intraoperational applications of indocyanine green fluorescence imaging methods, the basics of the technology, and instrumentation used is given.
Journal ArticleDOI

Structure-based programming of lymph-node targeting in molecular vaccines

TL;DR: In this article, an albumin hitchhiking approach was applied to molecular vaccines, through the synthesis of amphiphiles (amph-vaccines) comprising an antigen or adjuvant cargo linked to a lipophilic albumin-binding tail by a solubility-promoting polar polymer chain.

Structure-based programming of lymph-node targeting in molecular vaccines

TL;DR: Administration of structurally optimized CpG-DNA/peptide amph-vaccines in mice resulted in marked increases in LN accumulation and decreased systemic dissemination relative to their parent compounds, leading to 30-fold increases in T-cell priming and enhanced anti-tumour efficacy while greatly reducing systemic toxicity.
References
More filters
Journal ArticleDOI

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

TL;DR: The basic characteristics of the EPR effect, particularly the factors involved, are described, as well as its modulation for improving delivery of macromolecular drugs to the tumor.
Book

The Biology of Cancer

TL;DR: This book presents a meta-anatomy of Tumor Immunology and Immunotherapy, focusing on the role of immune checkpoints in the development of tumourigenesis and the maintenance of Genomic Integrity.
Journal ArticleDOI

In vivo imaging of tumors with protease-activated near-infrared fluorescent probes.

TL;DR: In vivo imaging showed a 12-fold increase in NIRF signal, allowing the detection of tumors with submillimeter-sized diameters, and this strategy can be used to detect such early stage tumors in vivo and to probe for specific enzyme activity.
Journal ArticleDOI

Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases

TL;DR: Hepatic resection is the treatment of choice for colorectal liver metastases and RFA alone or in combination with resection for unresectable patients does not provide survival comparable to resection, and provides survival only slightly superior to nonsurgical treatment.
Journal ArticleDOI

Liver resection for colorectal metastases.

TL;DR: Liver resection for colorectal metastases is safe and effective therapy and currently represents the only potentially curative therapy for metastatic coloreCTal cancer.
Related Papers (5)